A controlled trial of rasagiline in early Parkinson Disease. Arch Neurol 2002;59:1937-1943. Publication: Journal Article Group, Parkinson Study. 2002. “A Controlled Trial of Rasagiline in Early Parkinson Disease. Arch Neurol 2002;59:1937-1943.”. Arch Neurol.
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology 2001;56:455-462. Publication: Journal Article Group, Parkinson Study. 2001. “A Randomized, Controlled Trial of Remacemide For Motor Fluctuations in Parkinson’s Disease. Neurology 2001;56:455-462.”. Neurology.
Ropinirole in the treatment of Parkinson’s disease. Expert Opinion on Investigational Drugs 1999;8:697-710. Publication: Journal Article Zesiewicz, TA, and RA Hauser. 1999. “Ropinirole in the Treatment of Parkinson’s Disease. Expert Opinion on Investigational Drugs 1999;8:697-710.”. Expert Opinion on Investigational Drugs.
Depression and Anxiety in Parkinson’s Disease. American Journal of Geriatric Psychiatry. 1999;7:110-118. Publication: Journal Article Zesiewicz, TA, M Gold, G Chari, and RA Hauser. 1999. “Depression and Anxiety in Parkinson’s Disease. American Journal of Geriatric Psychiatry. 1999;7:110-118.”. Am J Geriatr Psych.
Clinical trials of add-on medications in Parkinson’s disease: efficacy versus usefulness. Parkinsonism & Related Disorders 1997;3:1-6. Publication: Journal Article Hauser, RA, TA Zesiewicz, SA Factor, M Guttman, and WJ Weiner. 1997. “Clinical Trials of Add-on Medications in Parkinson’s Disease: Efficacy versus Usefulness. Parkinsonism & Related Disorders 1997;3:1-6.”. Parkinsonism and Related Disorders.
Parkinson Study Group (including Hauser RA). Safety and efficacy of pramipexole in early Parkinson’s disease. A randomized dose-ranging study. JAMA 1997;278:125-130. Publication: Journal Article Group, Parkinson Study. 1997. “Parkinson Study Group (including Hauser RA). Safety and Efficacy of Pramipexole in Early Parkinson’s Disease. A Randomized Dose-Ranging Study. JAMA 1997;278:125-130.”. JAMA.
Toward the use of surgical placebo-controlled trials. Transplantation Proceedings1997;29:1925. Publication: Journal Article Freeman, TB, D Vawter, CG Goetz, PE Leaverton, RA Hauser, PR Sanberg, JH Godbold, and CW Olanow. 1997. “Toward the Use of Surgical Placebo-Controlled Trials. Transplantation Proceedings1997;29:1925.”. Transplantation Proceedings.
Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Canadian Journal of Neurological Sciences 1996;23:95-98. Publication: Journal Article Hauser, RA, TA Zesiewicz, C Martinez, AS Rosemurgy, and CW Olanow. 1996. “Blood Manganese Correlates With Brain Magnetic Resonance Imaging Changes in Patients With Liver Disease. Canadian Journal of Neurological Sciences 1996;23:95-98.”. Canadian Journal of Neurological Sciences.
Will fetal striatal transplants correct the akinetic end-stage of Huntington's disease? Neurodegeneration 1996;5:189-192. Publication: Journal Article Borlongan, CV, S Polgar, TB Freeman, RA Hauser, DW Cahill, and PR Sanberg. 1996. “Will Fetal Striatal Transplants Correct the Akinetic End-Stage of Huntington’s Disease? Neurodegeneration 1996;5:189-192.”. Neurodegeneration.
The relationship of essential tremor to other movement disorders: report on 678 patients. Ann Neurol 1994;35:717-723. Publication: Journal Article Koller, WC, K Busenbark, K Miner, and Essential Tremor Study Group. 1994. “The Relationship of Essential Tremor to Other Movement Disorders: Report on 678 Patients. Ann Neurol 1994;35:717-723.”. Ann Neurol.